- Home
- BLTE vs HESM Comparison
BLTE vs HESM Comparison
Compare BLTE & HESM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BLTE | HESM |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.5B |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | BLTE | HESM |
|---|---|---|
| Price | $158.00 | $33.92 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 9 |
| Target Price | ★ $156.00 | $42.25 |
| AVG Volume (30 Days) | 250.7K | ★ 1.3M |
| Earning Date | 11-10-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 8.99% |
| EPS Growth | N/A | ★ 18.64 |
| EPS | N/A | ★ 2.81 |
| Revenue | N/A | ★ $1,613,000,000.00 |
| Revenue This Year | N/A | $11.67 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.97 |
| Revenue Growth | N/A | ★ 10.78 |
| 52 Week Low | $49.00 | $31.63 |
| 52 Week High | $170.25 | $44.14 |
Technical Indicators
Market Signals| Indicator | BLTE | HESM |
|---|---|---|
| Relative Strength Index (RSI) | 56.72 | 48.78 |
| Support Level | $153.56 | $33.17 |
| Resistance Level | $170.25 | $34.82 |
| Average True Range (ATR) | 6.34 | 0.48 |
| MACD | -1.18 | -0.11 |
| Stochastic Oscillator | 28.64 | 43.64 |
Price Performance
Historical ComparisonAbout BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
About HESM Hess Midstream LP Share
Hess Midstream LP owns, operates, develops, and acquires a diverse set of midstream assets and provides fee-based services to Hess and third-party customers. It conducts its business through three operating segments: gathering, processing and storage, and terminaling and exporting. The company derives the maximum revenue from the gathering segment. Its gathering segment consists of the following assets namely Natural Gas Gathering and Compression; Crude Oil Gathering and Produced Water Gathering and Disposal.